الفهرس 
ASCITES AND ASCITIC FLUID INFECTIONOnly 14 pages are availabe for public view
 |  | from | 233 |  |  |
| | | from | 233 | | |
Abstract
Bacterial infections are common and life-threatening in cirrhotic patients with ascites. Among patients who survived the first episode of SBP, about 70% experienced a recurrence within a year. Bacterial causative agent(s) and response to treatment were evaluated in 104 de- compensated cirrhotic patients with ascites who were presented to Tropical Medicine Depart- ment, Ain Shams University Hospitals from February 2019 to June 2022 were evaluated for incidence of SBP, bacterial causative agent(s) and response to treatment. They were divided into two groups: GA received Rifaximin (N=52) and GB received Norfloxacin (N=52), Diag- nostic paracentesis was done as needed for ascitic fluid analysis and culture, clinical and bac- teriological profile of SBP was recorded. The results showed that the ascitic fluid infection in patients was 28.8% in both group, with symptoms of abdominal pain (100%) and fever (63.3%). Culture negative neutrocytic ascites (CNNA) was in 63.33%, Monomicrobial non neutrocytic bacterascites was in 33.3% and polymicrobial ones was in 3.33%. The isolated bacteria were E. coli and Staph. coagulase negative, of 30 % in each group.